• News
  • Poster on planned phase II study at ASCO

Poster on planned phase II study at ASCO

Copenhagen, Denmark – May 30, 2017: Dr Anders Mellemgaard who is a leading clinician at University of Copenhagen Herlev Hospital in Denmark, will be presenting a poster at the June 2-6 ASCO Conference in Chicago. 

The poster is titled “Combination immunotherapy with IDO vaccine and PD-1 inhibitors in advanced NSCLC” and outlines IO Biotech's planned phase II study.